TOPIC CENTER
59 Articles
Updated Oct 5, 2026
Early Phase
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
Discovery & DevelopmentAmgen’s MariTide to Face Phase 3 Trials in Targeting Liver and Kidney Diseases
4 min read • 2 years ago -
Discovery & DevelopmentLexaria’s GLP-1 Study Shows Promising 8-Week Weight Loss Results
4 min read • 2 years ago -
Discovery & DevelopmentNanoform Collaborate on Takeda’s Plasma-Derived Therapy Development
4 min read • 2 years ago -
Discovery & DevelopmentHalda Raises $126M to Advance Novel Solid Tumor Therapies
4 min read • 2 years ago -
-
Discovery & DevelopmentViking Therapeutics Advances Obesity Drug to Phase 3 with $300M Clinical Program
4 min read • 2 years ago -
Discovery & DevelopmentRoche Accelerates Obesity Treatment Development with Carmot Acquisition
4 min read • 2 years ago -
Discovery & DevelopmentFormation Bio Secures $372 Million for AI-Driven Drug Development
4 min read • 2 years ago -
-
Discovery & DevelopmentRezdiffra Launches as First MASH Treatment with Promising Rapid Uptakes
4 min read • 2 years ago -
Discovery & DevelopmentViking Therapeutics’ Obesity Drug Exceeds Competitors
4 min read • 3 years ago -
Stay Ahead in Pharma Intelligence
Join industry executives receiving our market briefings.
